ORIGINALValoración del riesgo/beneficio en el tratamiento de la enfermedad de Alzheimer. A propósito de una interacciónRisk/benefit assessment in the treatment of Alzheimer's disease. Drug interactions

Introduction Anticholinergic drugs reduce the efficacy of acetylcholinesterase inhibitors (AChEI) and are inappropriate in elderly patients. The aim of this study is to determine the prevalence rate of prescription AChEI drugs and anticholinergics in a Healthcare Area, to identify the affected patients, and to inform the attending physicians, in order to evaluate the suitability of treatments.